Effect of subtype-selective adenosine receptor antagonists on basal or haloperidol-regulated striatal function

Studies of exploratory locomotion and c-Fos immunoreactivity in outbred and A2AR KO mice

M. Pardo, L. López-Cruz, O. Valverde, C. Ledent, Y. Baqi, C. E. Müller, J. D. Salamone, M. Correa

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Behavioral activation is regulated by dopamine (DA) in striatal areas. At low doses, while typical antipsychotic drugs produce psychomotor slowing, psychostimulants promote exploration. Minor stimulants such as caffeine, which act as adenosine receptor antagonists, can also potentiate behavioral activation. Striatal areas are rich in adenosine and DA receptors, and adenosine A2A receptors are mainly expressed in the striatum where they are co-localized with DA D2 receptors. Adenosine antagonists with different receptor-selectivity profiles were used to study spontaneous or haloperidol-impaired exploration and c-Fos expression in different striatal areas. Because A2A antagonists were expected to be more selective for reversing the effects of the D2 antagonist haloperidol, A2A receptor knockout (A2ARKO) mice were also assessed. CD1 and A2ARKO male mice were tested in an open field and in a running wheel. Only the A1/A2A receptor antagonist theophylline (5.0-15.0mg/kg) and the A2A antagonist MSX-3 (2.0mg/kg) increased spontaneous locomotion and rearing. Co-administration of theophylline (10.0-15.0mg/kg), and MSX-3 (1.0-3.0mg/kg) reversed haloperidol-induced suppression of locomotion. The A1 antagonist CPT was only marginally effective in reversing the effects of haloperidol. Although adenosine antagonists did not affect c-Fos expression on their own, theophylline and MSX-3, but not CPT, attenuated haloperidol induction of c-Fos expression. A2ARKO mice were resistant to the behavioral effects of haloperidol at intermediate doses (0.1mg/kg) in the open field and in the running wheel. A2A receptors are important for regulating behavioral activation, and interact with D2 receptors in striatal areas to regulate neural processes involved in exploratory activity.

Original languageEnglish
Pages (from-to)217-226
Number of pages10
JournalBehavioural Brain Research
Volume247
DOIs
Publication statusPublished - Jun 5 2013

Fingerprint

Purinergic P1 Receptor Antagonists
Corpus Striatum
Haloperidol
Locomotion
Theophylline
Knockout Mice
Running
Adenosine
Adenosine A2A Receptors
Purinergic P1 Receptors
Dopamine D2 Receptors
Dopamine Receptors
Caffeine
Antipsychotic Agents
Dopamine

Keywords

  • Accumbens
  • Behavioral activation
  • Dopamine
  • Psychomotor slowing
  • Theophylline

ASJC Scopus subject areas

  • Behavioral Neuroscience

Cite this

Effect of subtype-selective adenosine receptor antagonists on basal or haloperidol-regulated striatal function : Studies of exploratory locomotion and c-Fos immunoreactivity in outbred and A2AR KO mice. / Pardo, M.; López-Cruz, L.; Valverde, O.; Ledent, C.; Baqi, Y.; Müller, C. E.; Salamone, J. D.; Correa, M.

In: Behavioural Brain Research, Vol. 247, 05.06.2013, p. 217-226.

Research output: Contribution to journalArticle

@article{5af7e0be6f4d48df8bcdb2342a9eb8bf,
title = "Effect of subtype-selective adenosine receptor antagonists on basal or haloperidol-regulated striatal function: Studies of exploratory locomotion and c-Fos immunoreactivity in outbred and A2AR KO mice",
abstract = "Behavioral activation is regulated by dopamine (DA) in striatal areas. At low doses, while typical antipsychotic drugs produce psychomotor slowing, psychostimulants promote exploration. Minor stimulants such as caffeine, which act as adenosine receptor antagonists, can also potentiate behavioral activation. Striatal areas are rich in adenosine and DA receptors, and adenosine A2A receptors are mainly expressed in the striatum where they are co-localized with DA D2 receptors. Adenosine antagonists with different receptor-selectivity profiles were used to study spontaneous or haloperidol-impaired exploration and c-Fos expression in different striatal areas. Because A2A antagonists were expected to be more selective for reversing the effects of the D2 antagonist haloperidol, A2A receptor knockout (A2ARKO) mice were also assessed. CD1 and A2ARKO male mice were tested in an open field and in a running wheel. Only the A1/A2A receptor antagonist theophylline (5.0-15.0mg/kg) and the A2A antagonist MSX-3 (2.0mg/kg) increased spontaneous locomotion and rearing. Co-administration of theophylline (10.0-15.0mg/kg), and MSX-3 (1.0-3.0mg/kg) reversed haloperidol-induced suppression of locomotion. The A1 antagonist CPT was only marginally effective in reversing the effects of haloperidol. Although adenosine antagonists did not affect c-Fos expression on their own, theophylline and MSX-3, but not CPT, attenuated haloperidol induction of c-Fos expression. A2ARKO mice were resistant to the behavioral effects of haloperidol at intermediate doses (0.1mg/kg) in the open field and in the running wheel. A2A receptors are important for regulating behavioral activation, and interact with D2 receptors in striatal areas to regulate neural processes involved in exploratory activity.",
keywords = "Accumbens, Behavioral activation, Dopamine, Psychomotor slowing, Theophylline",
author = "M. Pardo and L. L{\'o}pez-Cruz and O. Valverde and C. Ledent and Y. Baqi and M{\"u}ller, {C. E.} and Salamone, {J. D.} and M. Correa",
year = "2013",
month = "6",
day = "5",
doi = "10.1016/j.bbr.2013.03.035",
language = "English",
volume = "247",
pages = "217--226",
journal = "Behavioural Brain Research",
issn = "0166-4328",
publisher = "Elsevier",

}

TY - JOUR

T1 - Effect of subtype-selective adenosine receptor antagonists on basal or haloperidol-regulated striatal function

T2 - Studies of exploratory locomotion and c-Fos immunoreactivity in outbred and A2AR KO mice

AU - Pardo, M.

AU - López-Cruz, L.

AU - Valverde, O.

AU - Ledent, C.

AU - Baqi, Y.

AU - Müller, C. E.

AU - Salamone, J. D.

AU - Correa, M.

PY - 2013/6/5

Y1 - 2013/6/5

N2 - Behavioral activation is regulated by dopamine (DA) in striatal areas. At low doses, while typical antipsychotic drugs produce psychomotor slowing, psychostimulants promote exploration. Minor stimulants such as caffeine, which act as adenosine receptor antagonists, can also potentiate behavioral activation. Striatal areas are rich in adenosine and DA receptors, and adenosine A2A receptors are mainly expressed in the striatum where they are co-localized with DA D2 receptors. Adenosine antagonists with different receptor-selectivity profiles were used to study spontaneous or haloperidol-impaired exploration and c-Fos expression in different striatal areas. Because A2A antagonists were expected to be more selective for reversing the effects of the D2 antagonist haloperidol, A2A receptor knockout (A2ARKO) mice were also assessed. CD1 and A2ARKO male mice were tested in an open field and in a running wheel. Only the A1/A2A receptor antagonist theophylline (5.0-15.0mg/kg) and the A2A antagonist MSX-3 (2.0mg/kg) increased spontaneous locomotion and rearing. Co-administration of theophylline (10.0-15.0mg/kg), and MSX-3 (1.0-3.0mg/kg) reversed haloperidol-induced suppression of locomotion. The A1 antagonist CPT was only marginally effective in reversing the effects of haloperidol. Although adenosine antagonists did not affect c-Fos expression on their own, theophylline and MSX-3, but not CPT, attenuated haloperidol induction of c-Fos expression. A2ARKO mice were resistant to the behavioral effects of haloperidol at intermediate doses (0.1mg/kg) in the open field and in the running wheel. A2A receptors are important for regulating behavioral activation, and interact with D2 receptors in striatal areas to regulate neural processes involved in exploratory activity.

AB - Behavioral activation is regulated by dopamine (DA) in striatal areas. At low doses, while typical antipsychotic drugs produce psychomotor slowing, psychostimulants promote exploration. Minor stimulants such as caffeine, which act as adenosine receptor antagonists, can also potentiate behavioral activation. Striatal areas are rich in adenosine and DA receptors, and adenosine A2A receptors are mainly expressed in the striatum where they are co-localized with DA D2 receptors. Adenosine antagonists with different receptor-selectivity profiles were used to study spontaneous or haloperidol-impaired exploration and c-Fos expression in different striatal areas. Because A2A antagonists were expected to be more selective for reversing the effects of the D2 antagonist haloperidol, A2A receptor knockout (A2ARKO) mice were also assessed. CD1 and A2ARKO male mice were tested in an open field and in a running wheel. Only the A1/A2A receptor antagonist theophylline (5.0-15.0mg/kg) and the A2A antagonist MSX-3 (2.0mg/kg) increased spontaneous locomotion and rearing. Co-administration of theophylline (10.0-15.0mg/kg), and MSX-3 (1.0-3.0mg/kg) reversed haloperidol-induced suppression of locomotion. The A1 antagonist CPT was only marginally effective in reversing the effects of haloperidol. Although adenosine antagonists did not affect c-Fos expression on their own, theophylline and MSX-3, but not CPT, attenuated haloperidol induction of c-Fos expression. A2ARKO mice were resistant to the behavioral effects of haloperidol at intermediate doses (0.1mg/kg) in the open field and in the running wheel. A2A receptors are important for regulating behavioral activation, and interact with D2 receptors in striatal areas to regulate neural processes involved in exploratory activity.

KW - Accumbens

KW - Behavioral activation

KW - Dopamine

KW - Psychomotor slowing

KW - Theophylline

UR - http://www.scopus.com/inward/record.url?scp=84876806918&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876806918&partnerID=8YFLogxK

U2 - 10.1016/j.bbr.2013.03.035

DO - 10.1016/j.bbr.2013.03.035

M3 - Article

VL - 247

SP - 217

EP - 226

JO - Behavioural Brain Research

JF - Behavioural Brain Research

SN - 0166-4328

ER -